女性一生卵巢细胞与分子图谱的范围综述
该范围综述系统检索了截至2025年8月的多组学卵巢研究,最终提取121项研究的数据,发现转录组分析占85%,且研究对象以育龄期个体为主,青春期前及围绝经/绝经后人群明显不足,研究间在分组定义、测序技术和数据分析方法上存在较大异质性。
要点
- 转录组研究占85%,蛋白组和表观组分别占16%和12%,多组学整合研究有限。
- 育龄期样本最多(n=91),青春期前及围绝经/绝经后人群研究不足。
- 研究间分组定义、测序技术和分析流程缺乏标准化,影响可重复性。
核心结论
- 多组学研究增进了对卵巢生命周期分子特征的认识,但研究人群分布不均且方法异质性大,需标准化并引入AI/ML整合多组学数据。
研究设计与样本
- 范围综述,系统检索Medline、Embase和Web of Science Core Collection截至2025年8月的文献,排除动物及卵巢病理研究,最终提取121项研究的数据。
主要发现
- 转录组分析最常见(n=103,85%),其次为蛋白组(n=19,16%)和表观基因组(n=14,12%)。
- 育龄期个体样本研究最多(n=91),高龄生殖年龄样本研究n=45,胎儿样本研究n=16。
- 研究间在参与者分组定义、测序技术和数据分析方法上存在显著差异,背景临床信息和分析流程报告缺乏标准化。
关键数值与推荐
- 多组学卵巢研究应标准化报告背景临床信息、数据分析方法和分析流程细节。
- 建议有效应用AI/ML方法进行多组学数据整合,以在有限样本量下提升单细胞和组织水平分析质量。
临床怎么用
- 解读卵巢多组学研究时需注意研究人群偏倚和方法异质性,谨慎外推至青春期前及围绝经/绝经后人群。
- 开展卵巢多组学研究时应参考本综述建议,规范报告临床背景和分析流程,并考虑AI/ML整合策略。
局限性
- 排除了动物模型和卵巢病理研究,可能限制对机制和疾病状态的覆盖。
- 青春期前及围绝经/绝经后人群研究不足,存在临床和伦理原因导致的代表性局限。
- 研究间方法异质性大,未进行定量合并分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With growing interest in ART, fertility preservation, and postmenopausal health of women, reproductive medicine is increasingly focused on characterizing oocytes and ovarian tissue composition, as well as understanding the molecular mechanisms that guide ovarian function throughout its lifecycle. High-throughput omics technologies have enabled the characterization of different molecular layers, leading to substantial advances in our understanding of their complex dynamics. However, not all molecular aspects are studied equally, and studies examining the same modalities often show inconsistencies, underscoring the need for data standardization and highlighting the potential for using transformative artificial intelligence and machine-learning (AI/ML) methods for ovary studies. OBJECTIVE AND RATIONALE: This study aims to evaluate how multi-omic studies have advanced our understanding of the ovarian lifecycle from fetal development to postmenopause. We systematically reviewed published studies that have investigated molecular/omic layers, including the genome, methylome, transcriptome, and proteome throughout ovarian development and aging. Our analysis identified key molecular and cellular patterns, highlighted inconsistencies across studies and addressed gaps in data analysis, interpretation, and reproducibility to guide future research. SEARCH METHODS: We conducted a systematic literature search of Medline (PubMed), Embase (Ovid), and Web of Science Core Collection (Clarivate) using a combination of controlled and free text terms for human ovary, oogenesis, folliculogenesis, ovary development and (epi)genome, transcriptome, proteome, and multi-omic mechanisms to find relevant articles published before August 2025. To focus the scope of the current review, studies of domesticated and farm animals, rodents and other model organisms, non-human primates, as well as those examining various human ovarian pathologies were excluded. OUTCOMES: The search identified 23 546 studies for screening, of which 637 full-text studies were assessed for eligibility. Subsequently, we extracted data from 121 studies. Most studies analyzed the transcriptome of oocytes, granulosa cells, and ovarian tissue from reproductive-age individuals (n = 91), with fewer studies examining samples from individuals of advanced reproductive age (n = 45) and fetal (n = 16) samples. Transcriptome analyses were most common (n = 103, 85%), followed by proteome (n = 19, 16%) and epigenome (n = 14, 12%) studies. We found substantial variation in how studies defined and reported participants' groups as well as in their sequencing technologies and data analysis methods, with a lack of standardized reporting of background clinical information, data analysis methods, and pipeline details. The key findings underscore the prevailing consensus on genes defining major ovarian cell types and their roles throughout the ovarian lifespan, from prenatal development to postmenopausal transformation. This review highlighted the underrepresentation of certain patient groups, particularly prepubertal and peri-/postmenopausal individuals, among researched populations, due to obvious clinical and ethical reasons. WIDER IMPLICATIONS: This scoping review offers a comprehensive overview and benchmark of the current state of high-throughput omics-based research on ovarian cellular composition and molecular dynamics. To address these shortcomings, we propose general recommendations for multi-omics ovary studies and emphasize the necessity for more thorough multi-omic data integration by effectively applying novel AI/ML approaches. They can potentially improve the quality of multi-omics analyses at both single-cell and tissue levels despite limited sample sizes and enable integration of molecular profiling data with clinical and radiology datasets, enabling a more comprehensive understanding of ovarian biology. Such advancements can enhance reproducibility of research findings and guide future research to deepen our understanding of ovarian biology and ultimately support the development of medical technologies for better preserving fertility and alleviating infertility. REGISTRATION NUMBER: A protocol was published a priori on the Open Science Framework (https://osf.io/z38gb/).
引用
- Obukhova D, Loid M, Schor M, et al. Mapping ovarian cellular and molecular landscape across the lifespan of women: a scoping review. Hum Reprod Update. 2026. PMID: 42467724. doi:10.1093/humupd/dmag018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。